Page last updated: 2024-10-31

metyrapone and Sarcoidosis, Pulmonary

metyrapone has been researched along with Sarcoidosis, Pulmonary in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Sarcoidosis, Pulmonary: Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BRUN, J1
REVOL, A1
PERRIN-FAYOLLE, M1

Other Studies

1 other study available for metyrapone and Sarcoidosis, Pulmonary

ArticleYear
[A NEW TEST OF GANGLIO-PULMONARY SARCOIDOSIS OF BESNIER-BOECK-SCHAUMANN: THE METHOPYRAPONE TEST. ITS DIAGNOSTIC AND ETIO-PATHOGENIC VALUE].
    Le Poumon et le coeur, 1964, Volume: 20

    Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Clinical Laboratory

1964